From: OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
Model input | Base case value | Distribution |
---|---|---|
Probabilities | ||
Repeat episode of RTI | 0.20 | β (SD: 0.05) |
Mortality repeat episode of RTI | 0.008 | β (SD: 0.001) |
Utility | ||
Case base | 0.94 | β (SD: 0.01) |
Repeat episode of RTI | 0.87 | β (SD: 0.2) |
Cost | ||
Repeat episode of RTI (US$) | 2022 | Γ (SD: 505) |
OM-85 BV × 3 Cycles of 10 days (US$) | 74 | Γ (SD: 18,5) |
OM-85 BV | ||
Reduction of probability of repeat RTI | 0.65 | LogN (SD: 0.07) |